GigCapital7 announced the pricing of its downsized $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “GIGGU”, Thursday, August 29, 2024.
The new SPAC intends to combine with a technology target in the AI, medtech, sustainability, and broader TMT sectors.
GigCapital7’s sponsor team is to be led by Chairman and Chief Executive Officer, Dr. Avi S. Katz, alongside Chief Financial Officer, Christine Marshall. Dr. Raluca Dinu, Raanan I. Horowitz, Karen Rogge, Professor Darius Moshfeghi, and Ambassador Adrian Zuckerman are to serve on the SPAC’s Board of Directors.
Total SPAC deal count for 2024 year-to-date is now 29. This offering is expected to close on Friday, August 30, 2024.
Craft Capital Management and EF Hutton are serving as joint book-running managers for the offering. DLA Piper LLP is serving as Issuer’s Counsel with Lucosky Brookman LLP serving as Underwriter’s Counsel. BPM LLC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
Vendome Acquisition Corporation I (NASDAQ:VNMEU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “VNMEU”, Wednesday, July 2, 2025. The new SPAC plans to focus its search on target business in the consumer sector operating in North America, Southeast Asia, and Europe....
Origin Investment Corp. I (NASDAQ:ORIQU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ORIQU”, Wednesday, July 2, 2025. The new SPAC aims to mount a broad search for a target with a strong management and both revenue and earnings growth potential....
1RT Acquisition Corp. (NASDAQ:ONCHU) announced the pricing of its $150 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “ONCHU”, Wednesday, July 2, 2025. The new SPAC plans to target company in the digital asset ecosystem involved in the creation, storage, exchange or management of such assets, whether...
D. Boral ARC Acquisition II Corp. (NASDAQ:ARBCU) has filed for a $250 million SPAC to give underwriter D. Boral a second in-house SPAC to pursue deals with. The new SPAC offers investors a 1/2 warrant and an initial 18-month time frame to complete a deal. D. Boral II’s sponsor may automatically extend this once by...
Ribbon (NASDAQ:RIBB) has entered into a definitive agreement to combine with Japanese biotech firm DRC Medicine at a pro forma equity value of $422 million. Tokyo-based DRC Medicine manufactures reusable anti-bacterial and anti-allergen wearables and aims to go deeper into the medical device and pharmaceutical space. Transaction Overview Ribbon is expected to provide $50.4 million...